• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由于无法激活烟酰胺磷酸核糖转移酶(NAMPT)信号传导,粒细胞-巨噬细胞集落刺激因子(GM-CSF)治疗对先天性中性粒细胞减少症患者无效。

GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling.

作者信息

Koch Corinna, Samareh Bardia, Morishima Tatsuya, Mir Perihan, Kanz Lothar, Zeidler Cornelia, Skokowa Julia, Welte Karl

机构信息

Department of Molecular Hematopoiesis, Hannover Medical School, Hannover, Germany.

Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital Tübingen, Tübingen, Germany.

出版信息

Ann Hematol. 2017 Mar;96(3):345-353. doi: 10.1007/s00277-016-2894-5. Epub 2016 Dec 14.

DOI:10.1007/s00277-016-2894-5
PMID:27966038
Abstract

Severe congenital neutropenia (CN) is a bone marrow failure syndrome characterized by an absolute neutrophil count (ANC) below 500 cells/μL and recurrent, life-threatening bacterial infections. Treatment with granulocyte colony-stimulating factor (G-CSF) increases the ANC in the majority of CN patients. In contrary, granulocyte-monocyte colony-stimulating factor (GM-CSF) fails to increase neutrophil numbers in CN patients in vitro and in vivo, suggesting specific defects in signaling pathways downstream of GM-CSF receptor. Recently, we detected that G-CSF induces granulopoiesis in CN patients by hyperactivation of nicotinamide phosphoribosyl transferase (NAMPT)/Sirtuin 1 signaling in myeloid cells. Here, we demonstrated that, in contrast to G-CSF, GM-CSF failed to induce NAMPT-dependent granulopoiesis in CN patients. We further identified NAMPT signaling as an essential downstream effector of the GM-CSF pathway in myelopoiesis.

摘要

严重先天性中性粒细胞减少症(CN)是一种骨髓衰竭综合征,其特征为绝对中性粒细胞计数(ANC)低于500个细胞/μL,并伴有反复发生的、危及生命的细菌感染。大多数CN患者使用粒细胞集落刺激因子(G-CSF)治疗后ANC会升高。相反,粒细胞-巨噬细胞集落刺激因子(GM-CSF)在体外和体内均无法增加CN患者的中性粒细胞数量,这表明GM-CSF受体下游的信号通路存在特定缺陷。最近,我们检测到G-CSF通过髓系细胞中烟酰胺磷酸核糖转移酶(NAMPT)/沉默调节蛋白1信号的过度激活来诱导CN患者的粒细胞生成。在此,我们证明,与G-CSF不同,GM-CSF无法在CN患者中诱导NAMPT依赖的粒细胞生成。我们进一步确定NAMPT信号是髓系造血中GM-CSF通路的重要下游效应器。

相似文献

1
GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling.由于无法激活烟酰胺磷酸核糖转移酶(NAMPT)信号传导,粒细胞-巨噬细胞集落刺激因子(GM-CSF)治疗对先天性中性粒细胞减少症患者无效。
Ann Hematol. 2017 Mar;96(3):345-353. doi: 10.1007/s00277-016-2894-5. Epub 2016 Dec 14.
2
NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway.烟酰胺磷酸核糖转移酶(NAMPT)通过烟酰胺腺嘌呤二核苷酸(NAD+)-沉默调节蛋白1(sirtuin-1)依赖的途径,对于粒细胞集落刺激因子(G-CSF)诱导的髓系分化至关重要。
Nat Med. 2009 Feb;15(2):151-8. doi: 10.1038/nm.1913. Epub 2009 Feb 1.
3
Defective G-CSFR signaling pathways in congenital neutropenia.先天性中性粒细胞减少症中 G-CSFR 信号通路的缺陷。
Hematol Oncol Clin North Am. 2013 Feb;27(1):75-88, viii. doi: 10.1016/j.hoc.2012.11.001. Epub 2012 Nov 27.
4
Dysregulation of myeloid-specific transcription factors in congenital neutropenia.先天性中性粒细胞减少症中髓系特异性转录因子的失调。
Ann N Y Acad Sci. 2009 Sep;1176:94-100. doi: 10.1111/j.1749-6632.2009.04963.x.
5
Case report: Granulocyte-macrophage colony-stimulating factor sargramostim did not rescue the neutrophil phenotype in two patients with JAGN1-mutant severe congenital neutropenia.病例报告:粒细胞-巨噬细胞集落刺激因子沙格司亭未能挽救两名 JAGN1 突变严重先天性中性粒细胞减少症患者的中性粒细胞表型。
Front Immunol. 2024 Sep 2;15:1373495. doi: 10.3389/fimmu.2024.1373495. eCollection 2024.
6
GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.粒细胞-巨噬细胞集落刺激因子可加速自体造血干细胞移植后中性粒细胞的恢复。
Bone Marrow Transplant. 1996 Dec;18(6):1057-64.
7
Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia.先天性中性粒细胞减少症患者的粒细胞集落刺激因子(G-CSF)产生及G-CSF受体结构
Blood. 1994 Mar 15;83(6):1486-92.
8
[GM-CSF and G-CSF: cytokines in clinical application].[粒细胞-巨噬细胞集落刺激因子与粒细胞集落刺激因子:临床应用中的细胞因子]
Schweiz Med Wochenschr. 1991 Mar 23;121(12):397-412.
9
Differential effects of IL-3, GM-CSF and G-CSF in an adult with congenital neutropenia.白细胞介素-3、粒细胞-巨噬细胞集落刺激因子和粒细胞集落刺激因子对一名先天性中性粒细胞减少症成人患者的不同作用。
Int J Hematol. 1992 Oct;56(2):113-8.
10
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.重组粒细胞-巨噬细胞集落刺激因子对肉瘤患者化疗所致骨髓抑制的消除作用:对祖细胞水平的保护
J Clin Oncol. 1992 Aug;10(8):1266-77. doi: 10.1200/JCO.1992.10.8.1266.

引用本文的文献

1
Case report: Granulocyte-macrophage colony-stimulating factor sargramostim did not rescue the neutrophil phenotype in two patients with JAGN1-mutant severe congenital neutropenia.病例报告:粒细胞-巨噬细胞集落刺激因子沙格司亭未能挽救两名 JAGN1 突变严重先天性中性粒细胞减少症患者的中性粒细胞表型。
Front Immunol. 2024 Sep 2;15:1373495. doi: 10.3389/fimmu.2024.1373495. eCollection 2024.
2
The Role of NAD and NAD-Boosting Therapies in Inflammatory Response by IL-13.NAD及NAD增强疗法在白细胞介素-13介导的炎症反应中的作用
Pharmaceuticals (Basel). 2024 Feb 8;17(2):226. doi: 10.3390/ph17020226.
3
SIRT1-SIRT7 Expression in Patients with Lymphoproliferative Disorders Undergoing Hematopoietic Stem Cell Mobilization.
造血干细胞动员的淋巴增殖性疾病患者中SIRT1 - SIRT7的表达
Cancers (Basel). 2022 Feb 25;14(5):1213. doi: 10.3390/cancers14051213.
4
Diagnosis and therapeutic decision-making for the neutropenic patient.中性粒细胞减少患者的诊断和治疗决策。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):492-503. doi: 10.1182/hematology.2021000284.
5
NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells.NAMPT/SIRT2 介导的抑制 p53-p21 信号通路对于维持和造血分化的人类诱导多能干细胞是必不可少的。
Stem Cell Res Ther. 2021 Feb 5;12(1):112. doi: 10.1186/s13287-021-02144-9.
6
NAD metabolism, stemness, the immune response, and cancer.NAD 代谢、干性、免疫反应和癌症。
Signal Transduct Target Ther. 2021 Jan 1;6(1):2. doi: 10.1038/s41392-020-00354-w.
7
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation.烟酰胺磷酸核糖转移酶(NAMPT)和烟酰胺磷酸核糖基转移酶(NAPRT):在炎症中起关键作用的两种代谢酶。
Front Oncol. 2020 Mar 19;10:358. doi: 10.3389/fonc.2020.00358. eCollection 2020.
8
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer.NAD 生物合成和消耗酶作为先天和适应性免疫反应在癌症代谢调控中的核心参与者。
Front Immunol. 2019 Jul 25;10:1720. doi: 10.3389/fimmu.2019.01720. eCollection 2019.
9
LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis.去乙酰化激活 LMO2 对于造血和 T-ALL 白血病发生是不可或缺的。
Blood. 2019 Oct 3;134(14):1159-1175. doi: 10.1182/blood.2019000095. Epub 2019 Jul 31.
10
Severe congenital neutropenias.严重先天性中性粒细胞减少症。
Nat Rev Dis Primers. 2017 Jun 8;3:17032. doi: 10.1038/nrdp.2017.32.